Marketing-authorisation holder
Glenmark Arzneimittel Gmbh
387 medicines in 4 countries, as authorisation holder and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder
387 medicines in 4 countries, as authorisation holder and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 387
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABACAVIR/LAMIVUDINA GLENMARK 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG676.401 mg + 300 mg · Comprimido recubierto con película | Abacavir, Lamivudine | Spain | Marketed | 2017 |
| Abacavir/Lamivudine Glenmark 600 mg/300 mg filmomhulde tablettenFilmomhulde tablet | Abacavir, Lamivudine | Netherlands | Authorised | 2017 |
| ABIRATERONA GLENMARK 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG500 mg · Comprimido recubierto con película | Abiraterone | Spain | Marketed | 2021 |
| ABISAX 20 MG COMPRIMIDOS EFG20 mg · Comprimido | Bilastine | Spain | Marketed | 2022 |
| Adapaleen/Benzoylperoxide Glenmark 1 mg/g + 25 mg/g gelGel | Adapalene, Benzoyl peroxide | Netherlands | Authorised | 2024 |
| Adapaleen/Benzoylperoxide Glenmark 3 mg/g + 25 mg/g gelGel | Adapalene, Benzoyl peroxide | Netherlands | Authorised | 2024 |
| ADISOCOL 150 MG COMPRIMIDOS EFG150 mg · Comprimido | Ursodeoxycholic acid | Spain | Marketed | 2018 |
| ADISOCOL 250 MG CAPSULAS DURAS EFG250 mg · Cápsula dura | Ursodeoxycholic acid | Spain | Authorised | 2024 |
| ADISOCOL 300 MG COMPRIMIDOS EFG300 mg · Comprimido | Ursodeoxycholic acid | Spain | Marketed | 2018 |
| ADISOCOL 450 MG COMPRIMIDOS EFG450 mg · Comprimido | Ursodeoxycholic acid | Spain | Marketed | 2018 |
| ADISOCOL 500 MG CAPSULAS DURAS EFG500 mg · Cápsula dura | Ursodeoxycholic acid | Spain | Marketed | 2024 |
| Agomelatine Glenmark 25 mg filmomhulde tablettenFilmomhulde tablet | Agomelatine | Netherlands | Authorised | 2018 |
| ANAGRELIDA GLENMARK 0,5 MG CAPSULAS DURAS EFG0,61 mg · Cápsula dura | Anagrelide | Spain | Marketed | 2018 |
| Anagrelide Glenmark 0,5 mg harde capsulesCapsule, hard | Anagrelide | Netherlands | Authorised | 2018 |
| ANAMAP 25 MG/G + 25 MG/G CREMA25 mg + 25 mg · Crema | Lidocaine, Prilocaine | Spain | Marketed | 2019 |
| APIXABAN GLENMARKCompressa rivestita con film | Apixaban | Italy | Authorised | |
| Apixaban Glenmark 2,5 mg filmomhulde tablettenFilmomhulde tablet | Apixaban | Netherlands | Authorised | 2026 |
| Apixaban Glenmark 5 mg filmomhulde tablettenFilmomhulde tablet | Apixaban | Netherlands | Authorised | 2026 |
| APIXABAN VISO FARMACEUTICA 1 MG/ML SUSPENSION ORAL1 mg · Suspensión oral | Apixaban | Spain | Authorised | 2026 |
| APIXABAN VISO FARMACEUTICA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG2,5 mg · Comprimido recubierto con película | Apixaban | Spain | Authorised | 2026 |
| APIXABAN VISO FARMACEUTICA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG5 mg · Comprimido recubierto con película | Apixaban | Spain | Authorised | 2026 |
| APREMILAST GLENMARKCompressa rivestita con film | Apremilast | Italy | Authorised | |
| APREMILAST GLENMARK 10 MG + 20 MG + 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG10 mg + 20 mg + 30 mg · Comprimido recubierto con película | Apremilast | Spain | Marketed | 2025 |
| APREMILAST GLENMARK 30 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG30 mg · Comprimido recubierto con película | Apremilast | Spain | Marketed | 2025 |
| Atomoxetine Glenmark 10 mg harde capsulesCapsule, hard | Atomoxetine | Netherlands | Authorised | 2018 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 201 | 201 | 0 | CompaniesAll medicines |
| Spain | 167 | 130 | 37 | CompaniesAll medicines |
| Italy | 17 | 17 | 0 | CompaniesAll medicines |
| European Union (EMA) | 2 | 2 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.